A SUMO4 initiator codon variant in amyotrophic lateral sclerosis reduces SUMO4 expression and alters stress granule dynamics

Background Recent evidence points toward a role of the small ubiquitin-like modifier (SUMO) system, including SUMO4, in protecting from stress insults and neurodegeneration, such as the progressive motor neuron disease amyotrophic lateral sclerosis (ALS), e.g., by regulating stress granule (SG) dynamics.

Here, we investigated whether SUMO4 variants play a role in ALS pathogenesis.

Methods Whole-exome or targeted SUMO4 sequencing was done in 222 unrelated European ALS patients.

The consequences of the identified initiator codon variant were analyzed at the mRNA, protein and cellular level.

SUMO4 expression was quantified in human tissues.

All patients were subjected to clinical, electrophysiological, and neuroradiological characterization.

Results A rare heterozygous SUMO4 variant, i.e., SUMO4 :c.2T>C p.Met1?

, was detected in four of 222 (1.8%) ALS patients, significantly more frequently than in two control cohorts (0.3% each).

SUMO4 mRNA and protein expression was diminished in whole blood or fibroblasts of a SUMO4 variant carrier versus controls.

Pertinent stress factors, i.e., head trauma or cancer (treated by radiochemotherapy), were significantly more frequent in SUMO4 variant carrier versus non-carrier ALS patients.

The mean number of SGs per cell was significantly higher in fibroblasts of a SUMO4 variant carrier compared to controls at baseline, upon oxidative stress, and after recovery, and SUMOylation of ALS-associated valosin-containing protein by SUMO4 was decreased.

SUMO4 mRNA expression was highest in brain of all human tissues analyzed.

Conclusions Our results are consistent with SUMO4 haploinsufficiency as a contributor to ALS pathogenesis impacting SG dynamics and possibly acting in conjunction with environmental oxidative stress-related factors.